Last reviewed · How we verify
3% Sodium Bicarbonate
3% Sodium Bicarbonate is a Small molecule drug developed by Riyadh Colleges of Dentistry and Pharmacy. It is currently FDA-approved. Also known as: 3% Na2CO3.
At a glance
| Generic name | 3% Sodium Bicarbonate |
|---|---|
| Also known as | 3% Na2CO3 |
| Sponsor | Riyadh Colleges of Dentistry and Pharmacy |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy of High-Level Laser Therapy in Managing Oral Mucositis Among Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation (NA)
- Comparison of Changes in Intra-myocardial Amino Acids During Use of Calafiore and Modified Del Nido Cardioplegia
- Oropharyngeal Care With Colostrum, Chlorohexidine and Sodium Bicarbonate in Preventing Ventilator-associated Pneumonia in Preterm Neonates (NA)
- Prevention of Oral Mucositis in Head and Neck Cancer. (NA)
- Oral Care With Maternal Milk in Mechanically Ventilated Preterm Infants (NA)
- Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals. (NA)
- Intra Oral Appliance (IOA) Model Evaluating the Efficacy of Sensitive Toothpaste (NA)
- Caffeine and Sodium Bicarbonate Supplementation Effects on Resistance Training Performance (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 3% Sodium Bicarbonate CI brief — competitive landscape report
- 3% Sodium Bicarbonate updates RSS · CI watch RSS
- Riyadh Colleges of Dentistry and Pharmacy portfolio CI
Frequently asked questions about 3% Sodium Bicarbonate
What is 3% Sodium Bicarbonate?
3% Sodium Bicarbonate is a Small molecule drug developed by Riyadh Colleges of Dentistry and Pharmacy.
Who makes 3% Sodium Bicarbonate?
3% Sodium Bicarbonate is developed and marketed by Riyadh Colleges of Dentistry and Pharmacy (see full Riyadh Colleges of Dentistry and Pharmacy pipeline at /company/riyadh-colleges-of-dentistry-and-pharmacy).
Is 3% Sodium Bicarbonate also known as anything else?
3% Sodium Bicarbonate is also known as 3% Na2CO3.
What development phase is 3% Sodium Bicarbonate in?
3% Sodium Bicarbonate is FDA-approved (marketed).
Related
- Manufacturer: Riyadh Colleges of Dentistry and Pharmacy — full pipeline
- Also known as: 3% Na2CO3
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing